| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Cocrystal Pharma, Inc.|
Txns:
| Granted 280,000 options to buy
@ $0.42, valued at
$117.6k
|
|
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2020 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.|
Txns:
| Granted 25,000 options
@ $1.1, valued at
$27.5k
|
|
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2020 |
3
| Kornberg Roger D. (Director) has filed a Form 3 on Cocrystal Pharma, Inc. |
| 12/06/2019 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.|
Txns:
| Granted 25,000 options
@ $1.31, valued at
$32.8k
|
|
| 11/30/2018 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.|
Txns:
| Granted 25,000 options
@ $3.05, valued at
$76.3k
|
|
| 11/17/2017 |
4
| Kornberg Roger D. (Director) has filed a Form 4 on Xenetic Biosciences, Inc.|
Txns:
| Granted 25,000 options
@ $2.18, valued at
$54.5k
|
|
| 12/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/21/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/11/2013 |
3
| Kornberg Roger D. (Director) has filed a Form 3 on OphthaliX, Inc. |
| 09/08/2008 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |